In order to overcome the low success rate of developing new medicine, we employ biomarker-based approaches to develop novel therapeutics that have optimized drug effect and delivery to the target tissue.
Animals are just as important to us
We strive to bring new medicine that can improve the lives of our animal companions.
R&D and Continuous Growth
We aim to thrive in the R&D ecosystem that requires long term survival by generating a stable cash flow.
Our Areas of Expertise.
Where we can make the biggest change in the future of medicine.
Small Molecule Drugs
Proteolysis Targeting Chimera (PROTAC)
Microneedle Platform Technology
CDO Services for Supergenerics and 505(b)(2) Products